Thyroid Carcinoma Management

Diagnosis and Prognosis

60-80% of newly detected thyroid carcinomas are micropapillary (<1cm) with excellent prognosis, as noted by the American Thyroid Association 1
Thyroid nodule management involves a comprehensive approach, including laboratory tests, diagnostic procedures, pathology, and treatment, as recommended by the National Comprehensive Cancer Network and the American Thyroid Association 2, 3, 4, 5

Serum TSH should be ordered with fine needle aspiration (FNA) as the primary laboratory test for TI-RADS 5 thyroid nodules, and ideally known before FNA is performed, though it may be impractical to wait for results before proceeding with FNA during the initial visit, as recommended by the National Comprehensive Cancer Network 6
Higher TSH levels are associated with increased risk for differentiated thyroid cancer, according to the National Comprehensive Cancer Network 6
Serum calcitonin is not routinely recommended for all thyroid nodules in the US, but should be considered if there are clinical features suggesting Medullary Thyroid Cancer (MTC), such as family history of MTC or Multiple Endocrine Neoplasia (MEN) syndromes, history of hyperparathyroidism, pheochromocytoma, presence of mucosal neuromas or marfanoid habitus, as recommended by the National Comprehensive Cancer Network 6
Fine needle aspiration (FNA) should not be delayed due to pending TSH results if it would significantly postpone diagnosis, as recommended by the National Comprehensive Cancer Network 6
Reassuring FNA results should not be relied upon solely when clinical findings are worrisome, as recommended by the National Comprehensive Cancer Network and the American Academy of Otolaryngology-Head and Neck Surgery 6, 7, 8

Ultrasound is the preferred first-line imaging modality for all palpable thyroid nodules, providing high-resolution imaging to confirm the palpable abnormality is within the thyroid, according to the American College of Radiology, with the TI-RADS risk stratification system used to guide further management decisions and assess malignancy risk, as follows:

TI-RADS Category	Ultrasound Characteristics	Risk of Malignancy
TI-RADS 2	Anechoic composition, well-defined margins, no solid components, no suspicious features	<2%
TI-RADS 3	Mixed composition, partially defined margins, some solid components, some suspicious features	2-10%
TI-RADS 4	Solid composition, poorly defined margins, many solid components, many suspicious features	10-50%
TI-RADS 5	Highly suspicious features, such as microcalcifications, irregular margins, and hypervascularity	>50%

Ultrasound guidance should be considered when initial palpation-guided FNA yields limited diagnostic utility, evaluating cystic or necrotic masses, or dealing with non-palpable nodules, with on-site evaluation by a cytopathologist reducing the inadequacy rate of FNA, and core biopsy is an option after an initial inadequate or indeterminate FNA, with high adequacy rate and accuracy 8

Pathology and cytopathology slides should be reviewed by a pathologist with expertise in thyroid disorders, as recommended by the National Comprehensive Cancer Network and the American Academy of Otolaryngology-Head and Neck Surgery 6, 7, 8
Some malignancies can mimic others cytologically, such as Hürthle cell neoplasms mimicking medullary carcinoma, metastatic renal carcinoma mimicking follicular neoplasm, melanoma mimicking medullary carcinoma, and metastatic lung cancer mimicking anaplastic carcinoma, according to the National Comprehensive Cancer Network and the American Academy of Otolaryngology-Head and Neck Surgery 6, 7, 8

Surgical intervention is indicated for nodules causing compressive symptoms, cosmetic concerns, nodules ≥2cm with gradual growth, suspicious features on imaging or cytology, or recurrence after multiple ablation attempts, as recommended by the International Journal of Surgery guidelines, the American Thyroid Association, and the National Comprehensive Cancer Network 3, 4, 2, 5
Thermal ablation is recommended for benign dominant thyroid nodules causing clinical symptoms, and nodules ≥2cm with gradual increase in size, as recommended by the International Journal of Surgery guidelines and supported by the American Thyroid Association 3, 11
Young age is a risk factor for malignancy, as noted by the National Comprehensive Cancer Network, and suspected lymphoma requires collection of material in tissue culture media for immunophenotypic analysis, while infection requires submission of some material for culture 8, 6
In pregnancy, propylthiouracil is preferred in the first trimester, then switched to methimazole, with the lowest effective dose to maintain FT4 in the upper normal range, as recommended by the American College of Radiology, and overtreatment of micropapillary carcinomas should be avoided, as 60-80% of newly detected thyroid carcinomas are micropapillary (<1 cm) with excellent prognosis, as noted by the American Thyroid Association 9, 12

Repeat thyroid function tests in 1-3 months, follow-up ultrasound in 3-6 months, and regular monitoring of weight and symptoms should be performed, with annual follow-up for stable, benign nodules, and regular neck ultrasound is the cornerstone of follow-up, with serum thyroglobulin measurement serving as a tumor marker, and the frequency of surveillance depending on risk stratification, as recommended by the National Comprehensive Cancer Network and the American College of Radiology 13, 2, 14, 10
Patient education should include reassurance about the benign nature of the nodule and instruction on self-monitoring for significant growth or symptoms, as recommended by the American College of Radiology 10